title: [The (putative) pathological impact of fibromyalgia on the orofacial system].
abstract: Fibromyalgia is a syndrome without apparent aetiology, characterised by pain, fatigue, memory disorders, mood disorders, and sleep disturbances. The syndrome is considered to be one of the rheumatic diseases. In the general population, the prevalence varies from 2 to 8%, with a women-men ratio of about 2:1. Suspicion of fibromyalgia arises when a patient has pain at multiple locations that cannot be attributed to trauma or inflammation, and when the pain is especially musculoskeletal. Primary management includes explaining the syndrome and offering reassurance. In addition, one can also attempt to increase mobility, avoid overloading, and improve physical condition and the level of activity, and to activate problem-solving skills. Subsequently, behavioural therapy and pharmacotherapy may be considered. The most important manifestations of fibromyalgia in the orofacial and occlusal system seem to be temporomandibular dysfunction, headache, xerostomia, hyposalivation, burning mouth and dysgeusia. However, with respect to the precise relation of fibromyalgia with the orofacial system, much needs to be elucidated.
authors.forename: C
authors.initials: C
authors.lastname: de Baat
authors.forename: A E
authors.initials: AE
authors.lastname: Gerritsen
authors.forename: M
authors.initials: M
authors.lastname: de Baat-Ananta
authors.forename: P
authors.initials: P
authors.lastname: de Baat
mesh_terms: D005157:Facial Pain / Q000453:epidemiology / Q000209:etiology; D005356:Fibromyalgia / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D006261:Headache / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D013705:Temporomandibular Joint Disorders / Q000453:epidemiology / Q000209:etiology; D014987:Xerostomia / Q000453:epidemiology / Q000209:etiology